AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)

CUSIP: 00288U106

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Shares, no par value per share
Shares outstanding
305,667,944
Total 13F shares
120,885,782
Share change
+1,708,478
Total reported value
$546,343,961
Put/Call ratio
177%
Price per share
$4.53
Number of holders
153
Value change
+$6,435,245
Number of buys
73
Number of sells
54

Security key

00288U106

Report period

Q1 2024

Institutions

153

Top holders

10

Top shareholders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAILLIE GIFFORD & CO
13F
Company
7.9%
24,044,796
$137,295,785 31 Dec 2023
13F
BAKER BROS. ADVISORS LP
13F
Company
7.5%
22,909,753
$130,814,690 31 Dec 2023
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
3.5%
10,624,185
$60,664,096 31 Dec 2023
13F
Capital World Investors
13F
Company
2.7%
8,351,293
$47,685,883 31 Dec 2023
13F
CREDIT SUISSE AG/
13F
Company
1.5%
4,578,250
$26,141,808 31 Dec 2023
13F
ORBIMED ADVISORS LLC
13F
Company
1.4%
4,180,768
$23,872,185 31 Dec 2023
13F
ArrowMark Colorado Holdings LLC
13F
Company
1.3%
4,105,095
$23,440,092 31 Dec 2023
13F
BlackRock Finance, Inc.
13F
Company
1.3%
3,905,713
$22,301,622 31 Dec 2023
13F
Founders Fund VII Management, LLC
13F
Company
1.2%
3,773,530
$21,546,856 31 Dec 2023
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
1.1%
3,412,005
$19,482,000 31 Dec 2023
13F
FEDERATED HERMES, INC.
13F
Company
1%
3,117,680
$17,801,953 31 Dec 2023
13F
Casdin Capital, LLC
13F
Company
0.77%
2,360,129
$13,476,337 31 Dec 2023
13F
FIL Ltd
13F
Company
0.61%
1,875,872
$10,711,229 31 Dec 2023
13F
GUARDIAN CAPITAL ADVISORS LP
13F
Company
0.58%
1,786,414
$10,664,892 31 Dec 2023
13F
Prosight Management, LP
13F
Company
0.56%
1,700,000
$9,707,000 31 Dec 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.48%
1,459,503
$8,334,000 31 Dec 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.41%
1,255,219
$7,167,300 31 Dec 2023
13F
Novo Holdings A/S
13F
Company
0.37%
1,126,915
$6,434,685 31 Dec 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.35%
1,069,238
$6,105,349 31 Dec 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.32%
993,300
$5,671,743 31 Dec 2023
13F
NORGES BANK
13F
Company
0.3%
922,214
$5,265,842 31 Dec 2023
13F
Intellectus Partners, LLC
13F
Company
0.29%
887,283
$5,066,384 31 Dec 2023
13F
Duquesne Family Office LLC
13F
Company
0.22%
659,750
$3,767,000 31 Dec 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.2%
601,241
$3,433,086 31 Dec 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.19%
578,306
$3,302,127 31 Dec 2023
13F
Belmont Capital, LLC
13F
Company
0.17%
510,000
$2,912,100 31 Dec 2023
13F
STATE STREET CORP
13F
Company
0.15%
460,900
$2,631,739 31 Dec 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.13%
409,259
$2,336,869 31 Dec 2023
13F
Founders Fund Growth Management, LLC
13F
Company
0.13%
407,017
$2,324,067 31 Dec 2023
13F
ROYAL BANK OF CANADA
13F
Company
0.13%
388,049
$2,216,000 31 Dec 2023
13F
MORGAN STANLEY
13F
Company
0.12%
376,890
$2,152,041 31 Dec 2023
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.11%
350,670
$2,002,000 31 Dec 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.11%
335,992
$1,918,514 31 Dec 2023
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.09%
289,886
$1,655,250 31 Dec 2023
13F
TD Waterhouse Canada Inc.
13F
Company
0.08%
258,130
$1,576,630 31 Dec 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
256,144
$1,462,582 31 Dec 2023
13F
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS
13F
Company
0.08%
250,248
$1,428,916 31 Dec 2023
13F
Jump Financial, LLC
13F
Company
0.08%
247,597
$1,413,779 31 Dec 2023
13F
PDT Partners, LLC
13F
Company
0.08%
247,378
$1,412,528 31 Dec 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.08%
243,440
$1,390,043 31 Dec 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
171,516
$979,357 31 Dec 2023
13F
TORONTO DOMINION BANK
13F
Company
0.05%
140,000
$799,400 31 Dec 2023
13F
ExodusPoint Capital Management, LP
13F
Company
0.04%
133,654
$763,000 31 Dec 2023
13F
BARCLAYS PLC
13F
Company
0.04%
120,657
$688,952 31 Dec 2023
13F
MACQUARIE GROUP LTD
13F
Company
0.04%
119,399
$682,000 31 Dec 2023
13F
Polar Asset Management Partners Inc.
13F
Company
0.04%
117,830
$672,809 31 Dec 2023
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.04%
117,555
$671,239 31 Dec 2023
13F
ArchPoint Investors
13F
Company
0.04%
115,055
$656,964 31 Dec 2023
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.04%
111,188
$634,883 31 Dec 2023
13F
DUALITY ADVISERS, LP
13F
Company
0.04%
111,041
$634,044 31 Dec 2023
13F

Institutional Holders of AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) as of Q1 2024

As of 31 Mar 2024, AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 120,885,782 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BAILLIE GIFFORD & CO, Voya Investment Management LLC, Capital World Investors, CREDIT SUISSE AG/, ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, BlackRock Inc., Founders Fund VII Management, LLC, and FEDERATED HERMES, INC.. This page lists 153 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
141
Q1 2024 holders
153
Holder diff
12
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .